Ivan Tesakov: Unraveling Platelet Dysfunction in ETV6-Related Thrombocytopenia
Ivan Tesakov, Research Fellow of Translational Hematology and Immunology at Tübingen University Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in British Journal of Haematology, adding:
“I am pleased to share that our work on ETV6-related thrombocytopenia has just been published in the British Journal of Haematology.
In this study, we identify impaired cytoskeletal organization as a key driver of platelet dysfunction in this rare disorder, leading to defective shape change and altered thrombus formation.
We also observe alterations in platelet–neutrophil cross-talk, further pointing to a broader dysregulation of thrombo-inflammatory processes.
These findings provide a mechanistic explanation for the bleeding phenotype observed in affected patients and may help inform future diagnostic and therapeutic approaches.
This work represents a large, long-term collaborative project.
For me, it is particularly meaningful as my first experience serving as corresponding author and as the culmination of a sustained joint effort.
I am very grateful to all co-authors and colleagues for their contributions.
I am always happy to discuss the work and answer any questions.”
Title: Altered cytoskeletal integrity underlies impaired platelet shape change and defective thrombus formation in ETV6-related thrombocytopenia
Authors: Ivan P. Tesakov, Julia-Jessica D. Korobkin, Daria V. Fedorova, Sofia V. Galkina, Maria M. Golomysova, Sergei I. Obydennyi, Anastasia A. Ignatova, Ekaterina-Iva A. Adamanskaya, Eugenia V. Yushkova, Anna V. Pavlova, Pavel A. Zharkov, Igor I. Kireev, Galina A. Novichkova, Viktor G. Zgoda, Mikhail A. Panteleev, Anastasia N. Sveshnikova
See more in the gallery.
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?